Management of sarcomatoid salivary duct carcinoma of the submandibular gland duct with coexisting seropositive human immunodeficiency virus

W. F. Mourad, K. S. Hu, R. A. Shourbaji, L. B. Harrison

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Sarcomatoid salivary duct carcinoma of the submandibular gland is extremely rare. This paper highlights the impact of surgery and adjuvant radiation therapy on the outcome of this disease. Methods: A 59-year-old man with human immunodeficiency virus presented with a painless, rapidly growing left neck mass. Biopsy followed by surgical excision of the left submandibular gland revealed sarcomatoid salivary duct carcinoma of the submandibular gland duct with perineural invasion and close margins, for which he underwent adjuvant radiotherapy. Post-operative positron emission tomography and computed tomography revealed no residual or metastatic disease. Pathological analysis of tumour-node-metastasis staging revealed a T2 N0 M0 (stage II) tumour. Results: The patient tolerated his treatment without serious acute or long-term side effects. There was no evidence of disease on comprehensive examination or on positron emission tomography or computed tomography scans at the 4.6-year follow up. Conclusion: Surgery followed by adjuvant radiotherapy provided practical locoregional control with acceptable toxicity. Further detailed case reports are warranted to optimise the management of this rare malignancy.

Original languageEnglish (US)
Pages (from-to)621-624
Number of pages4
JournalJournal of Laryngology and Otology
Volume127
Issue number6
DOIs
StatePublished - Jun 1 2013

Fingerprint

Salivary Ducts
Submandibular Gland
Adjuvant Radiotherapy
HIV
Carcinoma
Neoplasms
Neck
Radiotherapy
Neoplasm Metastasis
Biopsy
Positron Emission Tomography Computed Tomography
Therapeutics

Keywords

  • Carcinoma
  • Human Immunodeficiency Virus
  • Pathology
  • Radiotherapy
  • Salivary Ducts
  • Submandibular Gland

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Management of sarcomatoid salivary duct carcinoma of the submandibular gland duct with coexisting seropositive human immunodeficiency virus. / Mourad, W. F.; Hu, K. S.; Shourbaji, R. A.; Harrison, L. B.

In: Journal of Laryngology and Otology, Vol. 127, No. 6, 01.06.2013, p. 621-624.

Research output: Contribution to journalArticle

@article{a1baf45db61848d3b60e70d201cbb431,
title = "Management of sarcomatoid salivary duct carcinoma of the submandibular gland duct with coexisting seropositive human immunodeficiency virus",
abstract = "Background: Sarcomatoid salivary duct carcinoma of the submandibular gland is extremely rare. This paper highlights the impact of surgery and adjuvant radiation therapy on the outcome of this disease. Methods: A 59-year-old man with human immunodeficiency virus presented with a painless, rapidly growing left neck mass. Biopsy followed by surgical excision of the left submandibular gland revealed sarcomatoid salivary duct carcinoma of the submandibular gland duct with perineural invasion and close margins, for which he underwent adjuvant radiotherapy. Post-operative positron emission tomography and computed tomography revealed no residual or metastatic disease. Pathological analysis of tumour-node-metastasis staging revealed a T2 N0 M0 (stage II) tumour. Results: The patient tolerated his treatment without serious acute or long-term side effects. There was no evidence of disease on comprehensive examination or on positron emission tomography or computed tomography scans at the 4.6-year follow up. Conclusion: Surgery followed by adjuvant radiotherapy provided practical locoregional control with acceptable toxicity. Further detailed case reports are warranted to optimise the management of this rare malignancy.",
keywords = "Carcinoma, Human Immunodeficiency Virus, Pathology, Radiotherapy, Salivary Ducts, Submandibular Gland",
author = "Mourad, {W. F.} and Hu, {K. S.} and Shourbaji, {R. A.} and Harrison, {L. B.}",
year = "2013",
month = "6",
day = "1",
doi = "10.1017/S0022215113000820",
language = "English (US)",
volume = "127",
pages = "621--624",
journal = "Journal of Laryngology and Otology",
issn = "0022-2151",
publisher = "Cambridge University Press",
number = "6",

}

TY - JOUR

T1 - Management of sarcomatoid salivary duct carcinoma of the submandibular gland duct with coexisting seropositive human immunodeficiency virus

AU - Mourad, W. F.

AU - Hu, K. S.

AU - Shourbaji, R. A.

AU - Harrison, L. B.

PY - 2013/6/1

Y1 - 2013/6/1

N2 - Background: Sarcomatoid salivary duct carcinoma of the submandibular gland is extremely rare. This paper highlights the impact of surgery and adjuvant radiation therapy on the outcome of this disease. Methods: A 59-year-old man with human immunodeficiency virus presented with a painless, rapidly growing left neck mass. Biopsy followed by surgical excision of the left submandibular gland revealed sarcomatoid salivary duct carcinoma of the submandibular gland duct with perineural invasion and close margins, for which he underwent adjuvant radiotherapy. Post-operative positron emission tomography and computed tomography revealed no residual or metastatic disease. Pathological analysis of tumour-node-metastasis staging revealed a T2 N0 M0 (stage II) tumour. Results: The patient tolerated his treatment without serious acute or long-term side effects. There was no evidence of disease on comprehensive examination or on positron emission tomography or computed tomography scans at the 4.6-year follow up. Conclusion: Surgery followed by adjuvant radiotherapy provided practical locoregional control with acceptable toxicity. Further detailed case reports are warranted to optimise the management of this rare malignancy.

AB - Background: Sarcomatoid salivary duct carcinoma of the submandibular gland is extremely rare. This paper highlights the impact of surgery and adjuvant radiation therapy on the outcome of this disease. Methods: A 59-year-old man with human immunodeficiency virus presented with a painless, rapidly growing left neck mass. Biopsy followed by surgical excision of the left submandibular gland revealed sarcomatoid salivary duct carcinoma of the submandibular gland duct with perineural invasion and close margins, for which he underwent adjuvant radiotherapy. Post-operative positron emission tomography and computed tomography revealed no residual or metastatic disease. Pathological analysis of tumour-node-metastasis staging revealed a T2 N0 M0 (stage II) tumour. Results: The patient tolerated his treatment without serious acute or long-term side effects. There was no evidence of disease on comprehensive examination or on positron emission tomography or computed tomography scans at the 4.6-year follow up. Conclusion: Surgery followed by adjuvant radiotherapy provided practical locoregional control with acceptable toxicity. Further detailed case reports are warranted to optimise the management of this rare malignancy.

KW - Carcinoma

KW - Human Immunodeficiency Virus

KW - Pathology

KW - Radiotherapy

KW - Salivary Ducts

KW - Submandibular Gland

UR - http://www.scopus.com/inward/record.url?scp=84878787404&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878787404&partnerID=8YFLogxK

U2 - 10.1017/S0022215113000820

DO - 10.1017/S0022215113000820

M3 - Article

C2 - 23611084

AN - SCOPUS:84878787404

VL - 127

SP - 621

EP - 624

JO - Journal of Laryngology and Otology

JF - Journal of Laryngology and Otology

SN - 0022-2151

IS - 6

ER -